Lyell Immunopharma Inc (LYEL) — Long-term Investment Intensity
Lyell Immunopharma Inc (LYEL) has a Long-term Investment Intensity of 5.6% as of December 2025. Long-term investments of $19.00 Million represent 5.6% of total assets of $340.05 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check LYEL asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lyell Immunopharma Inc Long-term Investment Intensity (2019–2025)
This chart shows how Lyell Immunopharma Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the intensity stands at 5.6%, reflecting long-term investments of $19.00 Million against total assets of $340.05 Million USD. For the complete balance sheet picture, see LYEL asset base.
Annual Long-term Investment Intensity for Lyell Immunopharma Inc (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Lyell Immunopharma Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read LYEL current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 5.6% | $19.00 Million | $340.05 Million | ▼ -0.9 pp |
| 2024 | 6.5% | $32.01 Million | $490.86 Million | ▲ +0.1 pp |
| 2023 | 6.5% | $48.51 Million | $750.03 Million | ▼ -5.8 pp |
| 2022 | 12.3% | $115.04 Million | $937.56 Million | ▼ -17.0 pp |
| 2021 | 29.3% | $330.53 Million | $1.13 Billion | ▲ +11.3 pp |
| 2020 | 18.0% | $163.44 Million | $908.28 Million | ▲ +5.6 pp |
| 2019 | 12.4% | $68.98 Million | $555.63 Million | — |